INVESTIGATING THE CLINICAL SIGNIFICANCE AND UTILITY OF LOW FREQUENCY RAS MUTATIONS AS PREDICTORS OF LACK OF CLINICAL BENEFIT FROM CETUXIMAB MONOTHERAPY IN CHEMOTHERAPY-REFRACTORY METASTATIC COLORECTAL CANCER. Contract uri icon

Overview

Awards

Time

Date/time interval

  • 2014 - 2016